{ "case_number": "CAC-UDRP-108335", "time_of_filling": "2026-01-20 08:29:43", "domain_names": [ "novartiscne.com" ], "case_administrator": " Iveta Špiclová (Czech Arbitration Court) (Case admin)", "complainant": [ "Novartis AG " ], "complainant_representative": "Abion GmbH", "respondent": [ "Shawn Manamela" ], "respondent_representative": null, "factual_background": "

The Complainant is the proprietor of the NOVARTIS trademarks registered as a word and figurative mark in several classes across numerous countries all over the world. The Complainant based in Switzerland is the holding company of the Novartis Group, a global healthcare company that provides solutions to address the evolving needs of patients worldwide. The Complainant’s products are sold in numerous countries, among them South Africa. In 2024, The Novartis Group achieved net sales of USD<\/p>\n

50.3 billion, and total net income amounted to USD 11.9 billion and employed 75 883 full‑time equivalent employees as of December 31, 2024.<\/p>\n

The disputed domain name has been registered on June 17, 2025 and does not resolve to an active website. Registrant´s name was initially redacted for privacy.<\/p>\n

The addition of the term “CNE” is an abbreviation of the mention “cationic nanoemulsion” which is a term having relevance in the area of RNA Vaccines.<\/p>\n

A cease and desist letter sent to the Respondent was not answered.  <\/span><\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n


No administratively compliant Response has been filed.<\/p>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Dietrich Beier" ], "date_of_panel_decision": "2026-02-23 00:00:00", "informal_english_translation": "

Amongst many other trademarks, the Complainant is the proprietor of the International Trademark registration NOVARTIS 663765 registered on July 1, 1996 in several classes and designated for numerous countries, and being in effect.<\/p>", "decision_domains": { "novartiscne.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }